- (910) 248-4853
- 250 MacDougall Dr. Seven Lakes, NC 27376
Elevated homocysteine is a well-established driver of heart disease, stroke, cognitive decline, and B vitamin deficiency. What it is not — despite what many practitioners assume — is a reliable indicator of how well your methylation cycle is actually functioning. Understanding this distinction changes everything about how your results should be interpreted and acted on.
This is one of the most common and consequential misunderstandings in functional medicine. A normal homocysteine level does not mean your methylation cycle is functioning well. Homocysteine sits downstream in the methylation cycle — it can read normal even when SAM is critically low, SAH is elevated, and your entire methylation cycle is impaired.
I order homocysteine as part of a comprehensive assessment because it gives genuinely important information about cardiovascular risk and B vitamin status. Homocysteine is included in the Methylation Profile SAM/SAH test — because homocysteine alone does not reliably indicate whether you are under or overmethylating. Depending on the outcome of your assessment, I may also order it as a standalone test.
Understanding the Test
Homocysteine is a sulfur-containing amino acid produced as a natural byproduct when the body metabolizes methionine — the amino acid that initiates the methylation cycle. Every time SAM donates a methyl group to complete a reaction in the body, the residue eventually becomes homocysteine. Under normal conditions, homocysteine is then recycled back into methionine using vitamin B12 and/or folate, or converted into cysteine and glutathione using vitamin B6.
When this recycling process is impaired — due to B12, folate, or B6 requirements, or to a block in the transsulfuration pathway — homocysteine accumulates in the blood. Elevated homocysteine damages blood vessel walls, promotes clot formation, drives neuroinflammation, and increases the risk of cardiovascular disease, stroke, and cognitive decline. It is one of the most clinically well-studied cardiovascular biomarkers in medicine.
The test is a straightforward blood draw at LabCorp. I order it as part of a broader panel because it gives me important information about B vitamin sufficiency and cardiovascular risk — two things I need to know for every client whose treatment involves methylation support.
However, I am also clear with every client about what this test does not tell us: it does not reveal whether you are under or overmethylating, and it does not reflect the efficiency of the methylation cycle upstream. For that, the Methylation Profile SAM/SAH test is required, which includes homocysteine as a marker.
The Most Important Distinction on This Page
This is a widespread assumption in functional medicine — and it leads to serious clinical errors. Understanding why homocysteine cannot be used to assess methylation status is essential before acting on your results.
Homocysteine appears at the end of the methylation cycle, after SAM has already donated its methyl group and SAH has already formed. By the time homocysteine is produced, the most clinically important methylation events have already occurred — or failed to occur. A normal homocysteine level tells you nothing about what happened upstream at the SAM and SAH level, where methylation is actually regulated.
SAM can be critically depleted — causing widespread methylation failure across neurotransmitter production, gene expression, and detoxification — while homocysteine reads completely within the normal range. This happens because homocysteine recycling depends on B12 and/or folate, which can be adequate even when SAM production is insufficient. Treating a normal homocysteine result as confirmation that methylation is functioning correctly or even worse, that an elevated level means there is a methylation problem, is one of the most common errors I see from clients who have had previous functional testing.
Undermethylation and overmethylation require opposite treatment protocols. Giving methyl donors to an overmethylator can significantly worsen anxiety, racing thoughts, and mood instability. Homocysteine gives no information about which direction the methylation cycle is running. Only accurate methylation testing can distinguish between these two biotypes. The Methylation Profile SAM/SAH test includes homocysteine as a marker.
Homocysteine is a valuable cardiovascular and B vitamin marker — and I order it for exactly those reasons. But if you want to know whether you are under or overmethylating, whether your SAM levels are sufficient, and whether your methylation cycle is actually running efficiently, you need the Methylation Profile SAM/SAH test, which includes homocysteine as a marker.
What Elevated Homocysteine Actually Tells Us
Although homocysteine is not a methylation marker, elevated levels are clinically significant in their own right. These are the conditions and risks that elevated homocysteine is directly associated with — and why I take it seriously as part of a comprehensive assessment.
Elevated homocysteine damages the endothelium — the lining of blood vessels — and promotes atherosclerosis, arterial stiffening, and clot formation. It is an independent cardiovascular risk factor, particularly significant when combined with other markers of inflammation and oxidative stress.
High homocysteine is one of the most consistently replicated biomarkers associated with accelerated cognitive decline and Alzheimer's disease risk. Neuroinflammation driven by homocysteine excess is documented in multiple prospective studies. Lowering homocysteine through B vitamin intervention has shown measurable benefit for brain atrophy in clinical trials.
Homocysteine promotes a prothrombotic state — making blood more prone to clotting. Both ischemic stroke (clot-based) and venous thromboembolism are significantly more common in individuals with elevated homocysteine, particularly above 15 µmol/L.
Elevated homocysteine is one of the most reliable indicators that B12, folate, or B6 are functionally insufficient — even when standard serum levels appear adequate. This is because homocysteine accumulates when the enzymes that require these vitamins to process it are not functioning at full capacity.
Elevated homocysteine during pregnancy is associated with neural tube defects, placental abruption, preeclampsia, and recurrent miscarriage. Adequate folate and B12 status before and during pregnancy is critical — and homocysteine testing provides a functional measure of whether those nutrients are being adequately utilized.
Higher homocysteine levels are associated with reduced bone density and increased fracture risk, independently of other known risk factors. The mechanism involves impairment of collagen cross-linking in bone matrix — an effect that standard bone density scans do not capture until damage is already significant.
The B Vitamin Connection
The recycling of homocysteine back into methionine depends on three B vitamins working in concert. When inflammation is present or any of these are deficient — even functionally, when serum levels appear normal — homocysteine accumulates. The pattern of elevation, combined with other markers, helps identify nutrient requirements.
Depending on your biotype, B12 and/or folate support the remethylation pathway, acting as co-factors in the conversion of homocysteine back into methionine. This is part of the primary recycling route and is most commonly impaired in people with inflammation, poor absorption, or inadequate dietary intake.
B6 drives the transsulfuration pathway — converting homocysteine forward into cysteine and then glutathione, the body’s primary antioxidant. This pathway is particularly relevant for clients with pyrrole disorder, since B6 is chronically depleted by HPL and the transsulfuration pathway is correspondingly impaired. For more on this connection, see the urine kryptopyrrole test page.
It is important to note — as my site explains in detail — that folate is a de-methylating agent and is contraindicated in undermethylation. However, elevated homocysteine is the specific indicator that folate support is needed to reduce homocysteine in an undermethylated individual until levels normalize — separate from the broader picture assessed by the Methylation Profile.
Homocysteine vs. Methylation Profile SAM/SAH
These two tests are frequently confused — and frequently ordered when only one should be. Here is exactly what each one reveals and why they answer different questions.
How It Works
The homocysteine test is a standard blood draw at your nearest LabCorp location. Here is what the process looks like.
We spend 20 minutes talking through your symptoms, history, and health goals. I will advise on which combination of tests makes the most sense for your situation — homocysteine is rarely ordered in isolation.
After sign-up, we complete a full intake session. I order homocysteine alongside methylation and any other relevant markers — all drawn at LabCorp in a single visit. I provide your full requisition form.
You visit your nearest LabCorp location at your convenience. The blood draw takes just a few minutes. Results are typically returned within 1 to 2 weeks. Fasting is required for accuracy.
Once all results are in, I build your starting treatment plan. Homocysteine is interpreted alongside methylation status, and your full clinical picture — not as a standalone number. We then meet monthly with updates and you can message me between sessions.
years in practice
Why Work With Samantha
Many clients come to me having already been tested for homocysteine by a functional medicine practitioner who told them their methylation was fine because their homocysteine was normal. Then we run the SAM/SAH Methylation Profile and find significantly depleted SAM and low methionine that has been driving their anxiety, OCD, and sleep problems for years.
I also want to be clear about a specific issue with folate and methylation one that I discuss on my site in detail. Folate is a de-methylating agent and homocysteine elevation is the specific clinical indicator that folate intervention is warranted. Supplementing methylfolate based on MTHFR genetics alone — without measuring both homocysteine and methylation — is a common and potentially harmful approach. Testing first, always.
Common Questions
Homocysteine is a sulfur-containing amino acid produced as a byproduct when the body metabolizes methionine. Under normal conditions it is recycled back into methionine using B12 and folate, or converted into cysteine and glutathione using B6. When these B vitamins are insufficient, homocysteine accumulates — damaging blood vessels, promoting clot formation, driving neuroinflammation, and increasing the risk of cardiovascular disease, stroke, and cognitive decline. It is one of the most well-studied cardiovascular biomarkers in medicine and a reliable indicator of functional B vitamin sufficiency.
No — and this is one of the most important points on this page. Normal homocysteine is compatible with severely impaired methylation. I have tested many clients with normal homocysteine who had significantly depleted SAM, elevated SAH, and a methylation index that explained years of unresolved depression, anxiety, and cognitive symptoms. The two tests answer different questions. Homocysteine tells you about cardiovascular risk and B vitamin sufficiency. The SAM/SAH Methylation Profile tells you whether your methylation cycle is actually running efficiently and whether you are under or overmethylating, it also includes homocysteine.
Pyrrole disorder chronically depletes vitamin B6 through urinary excretion of HPL — the compound that carries B6 out of the body. Since B6 is required for the transsulfuration pathway that converts homocysteine into cysteine and glutathione, pyroluric individuals have an added challenge with low B6 levels. Elevated homocysteine in someone with pyrrole disorder often reflects B6 deficiency as much as B12 or folate requirements. This is why I almost always assess pyrrole disorder alongside methylation and homocysteine testing — see the urine kryptopyrrole test page for more on this connection.
I do not take insurance or provide superbills, but homocysteine testing is often at least partially covered by insurance, particularly when ordered with a documented clinical indication such as cardiovascular risk assessment or monitoring of B vitamin supplementation. You may be able to submit your service receipt to your insurance company for partial reimbursement. During your discovery call I can walk you through current pricing. I will always advise on the most cost-effective approach to getting you the information we need.
Because homocysteine sits downstream in the methylation cycle, after the most clinically significant methylation events have already occurred. SAM — the molecule that actually drives methylation — can be critically depleted while homocysteine reads completely normal. This happens because homocysteine recycling uses B12 and folate, which can be adequate even when SAM production is insufficient for other reasons. A normal homocysteine level does not mean your methylation is functioning well. It means your B12, folate, and B6 pathways are adequately processing the homocysteine that the cycle is producing. The only direct measure of methylation cycle efficiency is the SAM/SAH ratio from the Methylation Profile test.
The standard lab reference range is typically 4.0 to 15.0 µmol/L. In functional medicine, optimal levels are considered to be below 7.0 µmol/L. Levels above 10.0 are a clinical concern regardless of what the standard lab reference shows, and levels above 15.0 represent significant elevation warranting prompt intervention with B12, folate, B6, and/or TMG. Results are always interpreted in the context of your full clinical picture — including your methylation status, and symptom history.
No — and this is an area where well-intentioned supplementation often goes wrong. Methylfolate is not a better form of folate. It is simply a different, more expensive form. In the end, all forms of folate perform the same function. Methylfolate may act faster, but it is not better. Folate is required to reduce homocysteine, but it has a duality: it donates some methyl outside the cell’s nucleus (in the cytoplasm), yet steals 10 times more methyl than it donates, making it a de-methylating agent. This can be helpful for an overmethylator that creates too many methyl groups, but it can be devastating for an undermethylator that does not. The nucleus is the cell’s command center where our DNA lies and where we’re trying to create change. This is why testing is critical for the appropriate use of folate supplementation.
Yes. I work with international clients regularly. The blood draw needs to happen at a LabCorp location in the United States. Canadian clients and those near the US border can arrange to cross for the draw. I have several clients in Vancouver, BC who manage this routinely. Reach out during your discovery call and we will find the right solution for your location.
Schedule your free 20-minute discovery call with Samantha. We will talk through your symptoms, your history, and the right combination of tests to give you a complete and accurate picture.